1. Home
  2. NSP

as of 07-21-2026 3:00pm EST

$50.99
$0.71
-1.37%
Stocks Consumer Discretionary Professional Services Nasdaq

Insperity Inc is a company that provides a wide range of human resources and business solutions designed to help businesses improve their performance. Small and midsize enterprises are the company's primary target customers. Majority of the company's products are offered through the company's Workforce Optimization and Workforce Synchronization solutions, which comprise various human resource functions, such as payroll and employment administration, employee benefits and compensation, government compliance, performance management, training and development services, and human capital management. The company generates all of its revenue in the United States.

Founded: 1986 Country:
United States
United States
Employees: N/A City: KINGWOOD
Market Cap: 1.8B IPO Year: 1996
Target Price: $47.67 AVG Volume (30 days): 679.9K
Analyst Decision: Hold Number of Analysts: 3
Dividend Yield:
6.45%
Dividend Payout Frequency: semi-annual
EPS: 0.88 EPS Growth: -107.85
52 Week Low/High: $18.57 - $61.65 Next Earning Date: 04-30-2026
Revenue: $6,812,000,000 Revenue Growth: 3.51%
Revenue Growth (this year): 3.45% Revenue Growth (next year): 6.95%
P/E Ratio: 58.75 Index: N/A
Free Cash Flow: -309000000.0 FCF Growth: N/A

AI-Powered NSP Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 20 hours ago

AI Recommendation

hold
Model Accuracy: 73.03%
73.03%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Stock Insider Trading Activity of Insperity Inc. (NSP)

SARVADI PAUL J

Chairman of the Board & CEO

Buy
NSP Jun 3, 2026

Avg Cost/Share

$34.05

Shares

233,000

Total Value

$7,933,650.00

Owned After

1,105,912

SEC Form 4

SARVADI PAUL J

Chairman of the Board & CEO

Buy
NSP May 5, 2026

Avg Cost/Share

$29.15

Shares

100,000

Total Value

$2,873,235.58

Owned After

1,105,912

SEC Form 4

Form 1 Form 2

Earnings Transcripts

SEC 8-K filings with transcript text

View All
2026
Q1

Q1 2026 Earnings

8-K SELL

Apr 30, 2026 · 100% conf.

AI Prediction SELL

1D

-4.20%

$34.08

5D

-7.88%

$32.77

20D

-9.05%

$32.35

Price: $35.57 Prob +5D: 0% AUC: 1.000
0001000753-26-000048

EX-99.1

2 a03312026-ex991earningsrel.htm

EX-99.1

Document

Exhibit 99.1

Insperity Announces First Quarter Results

HOUSTON – April 30, 2026 – Insperity, Inc. (NYSE: NSP), a leading provider of human resources and business performance solutions for America’s best businesses, today reported results for the first quarter ended March 31, 2026. Insperity will be hosting a conference call today at 5:00 p.m. ET to discuss these results and our 2026 outlook and will be posting an accompanying presentation to our investor website at http://ir.insperity.com.

Highlights for the quarter included:

•Q1 revenues up 2% year-over-year

•Q1 average paid WSEEs down 1% to 303,049

•Q1 net income of $33 million; adjusted EBITDA of $103 million

•Q1 diluted EPS of $0.88; adjusted EPS of $1.31

First Quarter Results

“We are pleased with our Q1 financial results, which reflect the effectiveness of our efforts to overcome margin pressure experienced in 2025,” said Paul J. Sarvadi, Insperity chairman and chief executive officer. “We are working to reestablish growth momentum over the balance of the year and to capitalize on the opportunity we see ahead in the evolving AI landscape for Insperity’s strategic HR services, technology, and expertise.”

The average number of worksite employees (“WSEE”) paid per month decreased 1% from Q1 2025 to 303,049 WSEEs. Revenues in Q1 2026 increased 2% to $1.9 billion on a 3% increase in revenue per WSEE on higher pricing, partially offset by the decrease in paid WSEEs.

Gross profit decreased 3% to $302 million in Q1 2026, which represents a significant improvement compared to the 21% decline we experienced in Q4 2025. These results reflect our margin recovery efforts, including our pricing, and client renewal strategy, the new contract terms with UnitedHealthcare, plan design changes and a slightly lower than expected claim cost trend. Our benefits costs per covered employee increased 5% over Q1 2025.

Operating expenses decreased 1% to $240 million in Q1 2026, including $9 million in restructuring charges primarily related to severance associated with a workforce realignment. Excluding the restructuring charges, operating expenses decreased 5% over Q1 2025. Operating expenses included $8 million in Q1 2026 and $13 million in Q1 2025 related to our Workday strategic partnership.

Reported net income was $33 million and diluted EPS was $0.88. Adjusted EBITDA and adjusted EPS were $103 million and $1.31, respectively.

“We are pleased with our gross profit results and the progress we have made in our margin recovery plan, which we expect to continue throughout 2026,” said James D. Allison, executive vice president of finance, chief financial officer and treasurer. “Our operating expenses in the first quarter of 2026 were slightly better than expected, reflecting the actions we have taken to align our cost structure with the needs of our business and to support profitability recovery.”

Cash outlays in the first three months of 2026 included the repurchase of approximately 171,000 shares of our common stock at a cost of $4 million, dividends totaling $23 million, and capital expenditures of $6 million. Adjusted cash at March 31, 2026 totaled $36 million and we had outstanding borrowings of $370 million under our credit facility.

2026 Guidance

The company also announced its updated guidance for 2026, including the second quarter of 2026. Please refer to the accompanying financial tables at the end of this press release for the reconciliation of non-GAAP financial measures to the comparable GAAP financial measures.

Q2 2026Full Year 2026

Average WSEEs paid302,500—304,500303,000—307,000

Year-over-year decrease

(2.1)%—(1.5)%(2.3)%—(1.0)%

Adjusted EPS1 $0.02—$0.50$1.60—$2.60

Year-over-year increase (decrease)(92)%—92%55%—152%

Adjusted EBITDA (in millions)$18—$46$170—$230

Year-over-year increase (decrease)(44)%—44%30%—76%


1 Adjusted EPS reflects an effective tax rate of 28% in Q2 2026 and 36% for the full year 2026 and 38.5 million outstanding shares for both Q2 and full year 2026.

Definition of Key Metrics

Average WSEEs paid — Determined by calculating the company’s cumulative WSEEs paid during the period divided by the number of months in the period.

Adjusted EPS — Represents diluted net income per share computed in accordance with GAAP, excluding the impact of non-cash stock-based compensation and restructuring charge.

Adjusted EBITDA — Represents net income computed in accordance with GAAP, plus interest expense, income taxes, depreciation and amortization expense, amortization of SaaS implementation costs, non-cash stock-based compensation, and restructuring charge.

Conference Call and Webcast

Insperity will be hosting a conference call today at 5:00 p.m. ET to discuss these results and the guidance discussed in this press release, and answer questions from investment analysts. To listen in, call 877-545-0523 and use conference i.d. number 830

2025
Q4

Q4 2025 Earnings

8-K BUY

Feb 10, 2026 · 97% conf.

AI Prediction BUY

1D

+1.56%

$34.18

Act: -10.87%

5D

+6.04%

$35.69

Act: -23.62%

20D

+5.62%

$35.55

Price: $33.66 Prob +5D: 98% AUC: 1.000
0001000753-26-000009

nsp-202602100001000753FALSE00010007532026-02-102026-02-100001000753us-gaap:CommonStockMember2026-02-102026-02-10

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported): February 10, 2026

Insperity, Inc. (Exact name of registrant as specified in its charter)

Delaware1-1399876-0479645 (State or other jurisdiction of incorporation)(Commission File Number)(I.R.S. Employer Identification No.)

19001 Crescent Springs Drive Kingwood, Texas 77339

(Address of principal executive offices and zip code)

Registrant’s telephone number, including area code: (281) 358-8986

Securities registered pursuant to Section 12(b) of the Act: Title of each classTicker symbol(s)Name of each exchange on which registered Common Stock, $.01 par value per shareNSPNew York Stock Exchange NYSE Texas

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under The Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under The Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). ☐ Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02. Results of Operations and Financial Condition. On February 10, 2026, Insperity, Inc. issued a press release announcing the company’s financial and operating results for the quarter and year ended December 31, 2025. A copy of the press release is furnished as Exhibit 99.1 hereto and incorporated by reference. The information in Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is being furnished to the SEC and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. This information shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 2.05. Costs Associated with Exit or Disposal Activities. On February 10, 2026, we announced an internal reorganization designed to improve the efficiency and align our workforce with our key areas of focus (the “Realignment Plan”). These actions are expected to result in the elimination of approximately 4% of our non-sales positions. We expect to continue disciplined hiring in sales and other key positions. We currently estimate that we will incur one-time charges of approximately $9 million in connection with the Realignment Plan, consisting primarily of cash expenditures for severance payments, employee benefits, and related costs. We expect that the majority of the charges will be incurred in the first quarter of 2026 and that the execution of the Realignment Plan will be substantially complete before the end of the first quarter of 2026. We intend to exclude the charges associated with the Realignment Plan from our non-GAAP financial measures. The charges that we expect to incur are subject to a number of assumptions, including requirements in applicable states jurisdictions, and actual expenses may differ from the estimates disclosed above. We may also incur charges and expenditures not currently contemplated due to unanticipated events that may occur in connection with the Realignment Plan.

Item 9.01. Financial Statements and Exhibits. (d)Exhibits

99.1— Press release regarding financial and operating results issued by Insperity, Inc. on February 10, 2026.

104Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

INSPERITY, INC.

By:/s/ Christian P. Callens

Christian P. Callens Senior Vice President of Legal, General Counsel & Secretary

Date: February 10, 2026

2025
Q3

Q3 2025 Earnings

8-K

Nov 3, 2025

0001000753-25-000104

nsp-202511030001000753FALSE00010007532025-11-032025-11-030001000753us-gaap:CommonStockMember2025-11-032025-11-03

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported): November 3, 2025

Insperity, Inc. (Exact name of registrant as specified in its charter)

Delaware1-1399876-0479645 (State or other jurisdiction of incorporation)(Commission File Number)(I.R.S. Employer Identification No.)

19001 Crescent Springs Drive Kingwood, Texas 77339

(Address of principal executive offices and zip code)

Registrant’s telephone number, including area code: (281) 358-8986

Securities registered pursuant to Section 12(b) of the Act: Title of each classTicker symbol(s)Name of each exchange on which registered Common Stock, $.01 par value per shareNSPNew York Stock Exchange NYSE Texas

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under The Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under The Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). ☐ Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 1.01. Entry into a Material Definitive Agreement. On November 3, 2025, a subsidiary of Insperity, Inc. (the "Company") entered into an amendment to its arrangement with UnitedHealthcare related to its medical coverage (the “Amendment”). The Amendment includes additional expected cost savings starting in 2026 and extends the arrangement through 2028; provides the Company with the option to annually elect to limit its responsibility for each participant’s claim costs to $500,000, $750,000, or $1,000,000 per year; revises certain administrative costs payable by the Company; and adds additional volume-based incentives, subject to certain conditions. The other previously disclosed material items remain unchanged. The foregoing summary is qualified in its entirety by reference to the agreement, a copy of which is filed as Exhibit 10.1 to this Form 8-K and is incorporated in this Item 1.01 by reference. A copy of the Company's press release announcing this amendment is attached as Exhibit 99.1.

Item 2.02. Results of Operations and Financial Condition. On November 3, 2025, Insperity, Inc. issued a press release announcing the company’s financial and operating results for the quarter ended September 30, 2025. A copy of the press release is furnished as Exhibit 99.1 hereto and incorporated by reference. The information in Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is being furnished to the SEC and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. This information shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01. Financial Statements and Exhibits. (d)Exhibits

10.1(+)Letter Agreement by and between Insperity Holdings, Inc. and UnitedHealthcare Insurance Company entered into as of November 3, 2025.

99.1— Press release regarding financial and operating results issued by Insperity, Inc. on November 3, 2025.

104Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.

(+)Certain portions of the exhibit have been omitted pursuant to Item 601(b)(10) of Regulation S-K. The omitted information is (i) not material and (ii) the type of information the Company treats as private or confidential.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

INSPERITY, INC.

By:/s/ Christian P. Callens

Christian P. Callens Senior Vice President of Legal, General Counsel & Secretary

Date: November 3, 2025

Share on Social Networks: